Ingunn Munch Lindvig

General Counsel presso BIOINVENT INTERNATIONAL AB

Health Technology

Consumer Services

Profilo

Ingunn Munch Lindvig is currently the Senior Vice President-Regulatory Affairs at BioInvent International AB since 2023.
Previously, she worked as the Head-Regulatory Affairs at Nordic Nanovector ASA and as the Vice President & Head-Regulatory Affairs at Circio Holding ASA. Dr. Lindvig holds a doctorate degree from the University of Oslo.

Posizioni attive di Ingunn Munch Lindvig

Società	Posizione	Inizio
BIOINVENT INTERNATIONAL AB	General Counsel	12/06/2023

Tutte le posizioni attive di Ingunn Munch Lindvig

Precedenti posizioni note di Ingunn Munch Lindvig

Società	Posizione	Fine
THOR MEDICAL	General Counsel	-
CIRCIO HOLDING ASA	General Counsel	-

Vedi nel dettaglio l'esperienza di Ingunn Munch Lindvig

Formazione di Ingunn Munch Lindvig

University of Oslo

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ingunn Munch Lindvig

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
BIOINVENT INTERNATIONAL AB	Health Technology
CIRCIO HOLDING ASA	Health Technology

Aziende private	1
Nordic Nanovector ASA Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway.	Health Technology